Figures & data
Table 1 Baseline demographic and clinical data of the patient population (n=123)
Figure 1 Reduction of pain intensity under tapentadol prolonged release during the 3-month observation period.
Abbreviation: NRS-11, 11-point numerical rating scale.
![Figure 1 Reduction of pain intensity under tapentadol prolonged release during the 3-month observation period.](/cms/asset/5a426663-ad3b-4b44-9ce4-cf0cf01b446e/djpr_a_72150_f0001_b.jpg)
Table 2 Responder analysis. Patients experiencing treatment success regarding pain reduction (parameter average pain intensity, n=123)
Table 3 Changes in quality of life and mental state during the 3-month observation (LOCF data, n=123)
Figure 2 Changes in pain-related impairments in daily life under tapentadol prolonged release (LOCF data, n=123).
Abbreviations: LOCF, last observation carried forward; mPDI, modified Pain Disability Index.
![Figure 2 Changes in pain-related impairments in daily life under tapentadol prolonged release (LOCF data, n=123).](/cms/asset/41576c1d-3846-4fd5-919e-7ab7a66b9bfc/djpr_a_72150_f0002_b.jpg)